SEC Final Pay vs. Performance Disclosure Rules: Planning for the 2023 Proxy Season and Investor Reactions
Kevin O’Connor and Mike Harlin Author Article on Patents and RNA-Based Therapeutics Published on BioProcess Online
Thomas Campbell Article on SCOTUS and the Scope of Enablement in Amgen v. Sanofi Published in IPWatchdog
